Finally, an increase in PD-L1 in the population of breast mesenchymal-like cancer cells, but specially in breast CSCs, has been observed during EMT by the EMT/β-catenin/STT3/PD-L1 signaling axis. The gene discussed is CD274; the disease is cancer.